Incidence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection who have normal alanine aminotransferase values

Journal of Medical Virology

Volumn 82, Issue 4, 2010, Pages 539-545

  Kumada, Takashi ^a   Toyoda, Hidenori ^a   Kiriyama, Seiki ^a   Sone, Yasuhiro ^a   Tanikawa, Makoto ^a   Hisanaga, Yasuhiro ^a   Kanamori, Akira ^a   Atsumi, Hiroyuki ^a   Takagi, Makiko ^a   Arakawa, Takahiro ^a   Fujimori, Masashi ^a  

^a OGAKI MUNICIPAL HOSPITAL   (Japan)

Author keywords

HBV DNA; Hepatitis B virus (HBV); Hepatocellular carcinoma; Normal alanine amino transferase; Platelet counts

Indexed keywords

ALANINE AMINOTRANSFERASE; CHOLESTEROL; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHEMICAL ANALYSIS; CHILD; CHOLESTEROL BLOOD LEVEL; ECHOGRAPHY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SCHOOL CHILD; SEROLOGY; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; CARCINOMA, HEPATOCELLULAR; CHILD; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B, CHRONIC; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; MIDDLE AGED; THROMBOCYTOPENIA; VIRAL LOAD; YOUNG ADULT;

HEPATITIS B VIRUS;

EID: 77949401124     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21686     Document Type: Article

References (34)

1. Beasley RP. 1988. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 61:1942-1956.
2. Beasley RP, Hwang LY, Lin CC, Chien CS. 1981. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22707 men in Taiwan. Lancet 2:1129-1133.
3. Caturelli E, Castellano L, Fusilli S, Palmentieri B, Niro GA, del Vecchio-Blanco C, Andriulli A, de Sio I. 2003. Coarse nodular US pattern in hepatic cirrhosis: Risk for hepatocellular carcinoma. Radiology 226:691-697.
4. Chan HL, Hui AY, Wong ML, Tse AM, Hung LC, Wong VW, Sung JJ. 2004. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. Gut 53:1494-1498.
5. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, Huang GT, Iloeje UH. 2006. REVEAL-HBV Study Group: Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295:65-73.
6. D'Arienzo A, Manguso F, Scaglione G, Vicinanza G, Bennato R, Mazzacca G. 1998. Prognostic value of progressive decrease in serum cholesterol in predicting survival in Child-Pugh C viral cirrhosis. Scand J Gastroenterol 33:1213-1218.
7. EASL Jury. 2003. EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002: Geneva, Switzerland. Consensus statement (short version). J Hepatol 38:533-540.
8. Iacobellis A, Fusilli S, Mangia A, Clemente R, Festa V, Giacobbe A, Facciorusso D, Niro G, Conoscitore P, Andriulli A. 2005. Ultrasonographic and biochemical parameters in the non-invasive evaluation of liver fibrosis in hepatitis C virus chronic hepatitis. Aliment Pharmacol Ther 22:769-774.
9. Ikeda K, Arase Y, Kobayashi M, Someya T, Hosaka T, Saitoh S, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Kumada H. 2005. Hepatitis B virus-related hepatocellular carcinogenesis and its prevention. Intervirology 48:29-38.
10. Kato H, Orito E, Sugauchi F, Ueda R, Gish RG, Usuda S, Miyakawa Y, Mizokami M. 2001. Determination of hepatitis B virus genotype G by polymerase chain reaction with hemi-nested primers. J Virol Methods 98:153-159.
11. Kiyosawa K, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Gad A, Tanaka E. 2004. Hepatocellular carcinoma: Recent trends in Japan. Gastroenterology 127:S17-S26.
12. Kudo M. 1999. Imaging diagnosis of hepatocellular carcinoma and premalignant/borderline lesions. Semin Liver Dis 19:297-309.
13. Kumada T, Toyoda H, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Kanamori A, Kondo J, Yamauchi T, Nakano S. 2007. Relation between incidence of hepatic carcinogenesis and integration value of alanine aminotransferase in patients with hepatitis C virus infection. Gut 56:738-739.
14. Liaw YF, Lin DY, Chen TJ, Chu CM. 1989. Natural course after the development of cirrhosis in patients with chronic type B hepatitis: A prospective study. Liver 9:235-241.
15. Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, Yuen H, Tanwandee T, Tao QM, Shue K, Keene ON, Dixon JS, Gray DF, Sabbat J. 2004. Cirrhosis Asian Lamivudine Multicentre Study Group. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 351:1521-1531.
16. Lok AS, McMahon BJ. 2004. Practice Guidelines Committee, American Association for the Study of Liver Diseases (AASLD): Chronic hepatitis B: Update of recommendations. Hepatology 39:857-861.
17. Lu SN, Wang JH, Liu SL, Hung CH, Chen CH, Tung HD, Chen TM, Huang WS, Lee CM, Chen CC, Changchien CS. 2006. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma. Cancer 107:2212-2222.
18. McMahon BJ, Holck P, Bulkow L, Snowball M. 2001. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus. Ann Intern Med 135:759-768.
19. Mommeja-Marin H, Mondou E, Blum MR, Rousseau F. 2003. Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: Analysis and review of the literature. Hepatology 37:1309-1319.
20. Murata K, Sugimoto K, Shiraki K, Nakano T. 2005. Relative predictive factors for hepatocellular carcinoma after HBeAg seroconversion in HBV infection. World J Gastroenterol 11:6848-6852.
21. Orito E, Ichida T, Sakugawa H, Sata M, Horiike N, Hino K, Okita K, Okanoue T, Iino S, Tanaka E, Suzuki K, Watanabe H, Hige S, Mizokami M. 2001. Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology 34:590-594.
22. Piao CY, Fujioka S, Iwasaki Y, Fujio K, Kaneyoshi T, Araki Y, Hashimoto K, Senoh T, Terada R, Nishida T, Kobashi H, Sakaguchi K, Shiratori Y. 2005. Lamivudine treatment in patients with HBV-related hepatocellular carcinoma-using an untreated, matched control cohort. Acta Med Okayama 59:217-224.
23. Prati D, Taioli E, Zanella A, Della Torre E, Butelli S, Del Vecchio E, Vianello L, Zanuso F, Mozzi F, Milani S, Conte D, Colombo M, Sirchia G. 2002. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 137:1-10.
24. Rustgi VK. 1987. Epidemiology of hepatocellular carcinoma. Gastroenterol Clin North Am 16:545-551.
25. Shen L, Li JQ, Zeng MD, Lu LG, Fan ST, Bao H. 2006. Correlation between ultrasonographic and pathologic diagnosis of liver fibrosis due to chronic virus hepatitis. World J Gastroenterol 28:1292-1295.
26. Sherman M. 2005. Predicting survival in hepatitis B. Gut 54:1521-1523.
27. Szmuness W. 1978. Hepatocellular carcinoma and the hepatitis B virus: Evidence for a causal association. Prog Med Virol 24:40-69.
28. Torzilli G, Minagawa M, Takayama T, Inoue K, Hui AM, Kubota K, Ohtomo K, Makuuchi M. 1999. Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology 30:889-893.
29. Wong CH, Chan SK, Chan HL, Tsui SK, Feitelson M. 2006. The molecular diagnosis of hepatitis B virus-associated hepatocellular carcinoma. Crit Rev Clin Lab Sci 43:69-101.
30. Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, Hsiao CK, Chen PJ, Chen DS, Chen CJ. 2002. Taiwan Community-Based Cancer Screening Project Group. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 347:168-174.
31. Yu MW, Chen CJ. 1994. Hepatitis B and C viruses in the development of hepatocellular carcinoma. Crit Rev Oncol Hematol 17:71-91.
32. Yu MW, Chang HC, Chen PJ, Liu CJ, Liaw YF, Lin SM, Lee SD, Lin SC, Lin CL, Chen CJ. 2002. Increased risk for hepatitis B-related liver cirrhosis in relatives of patients with hepatocellular carcinoma in northern Taiwan. Int J Epidemiol 31:1008-1015.
33. Yu MW, Yeh SH, Chen PJ, Liaw YF, Lin CL, Liu CJ, Shih WL, Kao JH, Chen DS, Chen CJ. 2005. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: A prospective study in men. J Natl Cancer Inst 97:265-272.
34. Yuen MF, Yuan HJ, Wong DK, Yuen JC, Wong WM, Chan AO, Wong BC, Lai KC, Lai CL. 2005. Prognostic determinants for chronic hepatitis B in Asians: Therapeutic implications. Gut 54:1610-1614.